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Edited by Felix WielandAbstract Calpains are a family of calcium-dependent cysteine
proteases involved in a variety of cellular functions. Two iso-
forms, m-calpain and l-calpain, have been implicated in cell
migration. However, since conventional inhibitors used for the
studies of the functions of these enzymes lack speciﬁcity, the
individual physiological function and biochemical mechanism of
these two isoforms, especially l-calpain, are not clear. In con-
trast, RNA interference has the potential to allow a sequence-
speciﬁc destruction of target RNA for functional assay of gene
of interest. In the present study, we found that small interfering
RNAs-mediated knockdown of l-calpain expression in MCF-7
cells that do not express m-Calpain led to a reduction of cell
migration. This isoform-speciﬁc function of l-calpain was fur-
ther conﬁrmed by the rescue experiment as overexpression of
l-calpain but not m-calpain could restore the cell migration rate.
Knockdown of l-calpain also altered cell morphology with in-
creased ﬁlopodial projections and a highly elongated tail that
seemed to prevent cell spreading and migration with reduced rear
detachment ability. Furthermore, knockdown of l-calpain de-
creased the proteolytic products of ﬁlamin and talin, which were
speciﬁcally rescued by overexpression of l-calpain but not m-cal-
pain, suggesting that their proteolysis could be one of the key
mechanisms by which l-calpain regulates cell migration.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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In multicellular organisms, cell migration is critical to many
normal and pathophysiological processes, such as embryonic
development, wound healing and tumor cell invasion and
metastasis. Cell migration consists of multiple of steps, includ-
ing extension of protrusions, formation of new cell-matrix
adhesions, contraction of cell body, and tail detachment [1].
Each of these biophysical processes is controlled coordinately*Corresponding author. Fax: +1 514 496 6319.
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doi:10.1016/j.febslet.2006.05.003by multiple biochemical signaling cascades. Cleavage of signal-
ing and cytoskeletal proteins by proteases plays an important
role in the regulation of such cascades [2].
The calpains are a large family of calcium-dependent
cysteine proteases, which consists of two well-conserved and
characterized proteins, l-calpain (calpain 1, CAPN1) and
m-calpain (calpain2, CAPN2), and at least 10 additional mam-
malian calpains [3]. Calpains cleave several components of fo-
cal adhesions, such as talin, paxillin and focal adhesion kinase,
resulting in disassembly of these complexes, remolding of cyto-
skeleton, loss of substrate adhesion and increased cell migra-
tion [4]. Calpain family members have been also implicated
in various other biological and pathological phenomena, such
as apoptosis, myoblast fusion, tumor metastasis, ischemic and
traumatic brain injury, Alzheimer’s disease, muscular dystro-
phy, and recently, type 2 diabetes [5–13]. Although speciﬁc cal-
pain isoforms dictate the speciﬁcity of some of these responses,
l-calpain and m-calpain, the two ubiquitous isoforms, are con-
sidered to play a vital role in most of these biological processes.
Both l-calpain and m-calpain are heterodimers composed of
a large 80 kDa catalytic subunit and a common small 30 kDa
regulatory subunit called calpain 4. They share 66% sequence
similarity but diﬀer in the concentration of calcium required
for activation in vitro. Millimolar level of calcium is required
for half-maximal activation for m-calpain in vitro, whereas
micromolar amounts of calcium is enough for l-calpain [3].
Up to now, no substrate speciﬁcity between these two isoforms
has been found. One major hinder is the lack of isoform-spe-
ciﬁc inhibitors for calpains [14–16]. Inhibition of calpain activ-
ity by diﬀerent pharmacological inhibitors, and calpastatin, the
endogenous inhibitor of calpains argues for the isoform-spe-
ciﬁc involvement of calpains. Furthermore, ﬁbroblasts from
calpain 4 gene knockout (calpain 4/) mice displayed de-
creased migration rates and loss of cytoskeletal stress ﬁbers,
without dissection of particular contribution of two calpain
isoforms to the observed phenotypes [17]. While many func-
tional studies are based on combined eﬀects of l-calpain and
m-calpain, the speciﬁc role of calpain isoforms in focal adhe-
sion dissociation and cell migration remains poorly under-
stood. Because l-calpain and m-calpains seem to have
diﬀerent distribution patterns in multiple subcellular locations
[18], they might contribute to cell migration in their distinct ex-
tents. Therefore, it is necessary to understand the role of eachblished by Elsevier B.V. All rights reserved.
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ment of Ca2+ concentration for activation by its autolyzed ac-
tive form is much closer to the physiological condition than
that of m-calpain on the basis of in vitro studies [3].
RNA interference (RNAi) has a great potential to distinguish
distinct functions of each member in a closely related gene fam-
ily or to selectively target a mutant gene, especially to study the
functions of a particular isoform [19,20]. Generally, many
eukaryotic genes are expressed as multiple isoforms through
the diﬀerential utilization of transcription/translation initiation
sites or alternative splicing. The conventional method to study
an isoform-speciﬁc function is either to express the isoform in a
clean background without the presence of other members, or to
use an isoform-speciﬁc inhibitor. However, these methods are
time-consuming and generally unavailable. Taking advantage
of the RNAi technology, human adaptor protein ShcA has
been investigated in an isoform-speciﬁc manner through sup-
pression of other non-target isoforms using common small
interfering RNAs (siRNA) [21]. In the very similar way, ﬁve
isoforms of vascular endothelial growth factor have also been
successfully studied [19]. RNAi strategy provides a novel tool
for studying the functions of various gene isoforms and may
contribute to exploiting human isoform-speciﬁc functions of
calpains in cell migration. Recently, Franco et al. utilized siR-
NAs to speciﬁcally knock down the expression of l-calpain
and m-calpain, and found that only m-calpain but not l-cal-
pain is involved in the regulation of membrane protrusion
and adhesion dynamics of ﬁbroblasts [22,23]. Because of the
diﬀerent expression patterns and diﬀerent subcellular locations
of l-calpain and m-calpain, we reasoned that l-calpain might
contribute to cell migration in other cell types although its func-
tion is not required in some ﬁbroblasts as reported by Franco
et al. [22,23]. In this study, we dissected the function of l-cal-
pain in cell migration using RNAi. We found that knockdown
of l-calpain inMCF-7 human breast cancer cells resulted in the
reduction of cell mobility, change of cell morphology and in-
creased stability of cytoskeletal proteins.2. Materials and methods
2.1. Materials and cell lines
Mouse anti-l-calpain monoclonal antibody was from Aﬃnity Bio-
Reagents (Golden, CO). Rabbit anti-m-calpain, mouse anti-Vinculin
(clone VIN-11-5), mouse anti-Talin (clone 8D4) and mouse anti-Actin
(clone AC-74) antibodies were purchased from Sigma (St. Louis, MO).
Mouse anti-Filamin A monoclonal antibodies (clones TI10 and PM6/
317) were obtained from Chemicon (Temecula, CA). Mouse and rabbit
anti-IgG-horseradish peroxidase conjugated polyclonal antibodies
were obtained from Bio-Rad (Hercules, CA). Nitrocellulose membrane
Hybond-ECL was purchased from Amersham Biosciences (Little
Chalfont, Buckinghamshire). ECL chemiluminescence reagent was
from Perkin–Elmer Life Science Inc (Boston, MA). Protease inhibitor
cocktail without EDTA was purchased from Roche Diagnostics (Indi-
anapolis, IN). Fibronectin of human plasma was purchased from Sig-
ma. MCF-7 cells (Human breast cancer cells) and HeLa cells (Human
cervical cancer cell line) were from American Type Culture Collection
and cultured in Dulbecco’s modiﬁed Eagle’s medium supplemented
with 10% fetal bovine serum at 37 C in a 5% CO2 atmosphere.
2.2. Plasmid construction for RNA interference
The vector-based RNAi constructs were built in the plasmid pSi-
lenceTM 3.1-H1 (Ambion, Austin, TX). Four siRNAs (Fig. 1A) were
designed using the siRNA target ﬁnder program from the Ambion
Inc. web page (www.ambion.com/techlib/misc/siRNA_ﬁnder.html)
and compared to the appropriate human genome database usingBLAST to eliminate from any target sequences with more than 16 con-
tiguous base pairs of homology to other coding sequences. SiRNAs
were then screened based on internal stability proﬁle [24,25]. Plasmid
vectors encoding a small hairpin RNA (shRNA) with two 19-mer-re-
verse and complementary stems separated by a 9-mer loop were con-
structed using pSilenceTM siRNA Construction Kit (Ambion,
Austin, TX) according to the manufacturer’s instructions.
2.3. Plasmid construction for protein expression in mammalian cells
Full-length l-calpain cDNA was ampliﬁed from a human brain
cDNA library by PCR using pfu DNA polymerase. The PCR product
was digested with NheI and XhoI and then cloned into the mammalian
expression vector pcDNA3.1 (Invitrogen) at the same sites. A silent
mutant of l-calpain carrying six mutant sites within the siRNA target-
ing sequence (Fig. 3A) was generated by PCR-based site-directed
mutagenesis to create plasmid pcDNA3.1/l-calpain-re.
2.4. Transfection and immunoblot analysis
HeLa cells and MCF-7 cells were transfected using Lipofectamine
2000 (Life Technologies, Inc.) as described in the manufacturer’s pro-
tocol. Stable cell lines were isolated by selection with 300 lg/ml of
hygromycin for three weeks after transfection. For immunoblot anal-
ysis, monolayer cells were washed twice with cold phosphate-buﬀered
saline (PBS), and lysed in lysis buﬀer (50 mMHEPES, pH 7.4, 150 mM
sodium chloride and 1% Triton X-100) containing EDTA-free protease
inhibitor cocktail. The samples were centrifuged at 13000 rpm for
5 min at 4 C to remove insoluble materials. Total protein was quanti-
ﬁed using the Bio-Rad Protein Assay kit with bovine serum albumin as
standard protein. The proteins were blotted onto nitrocellulose mem-
branes after separation by 7.5–10% SDS–PAGE. The membranes were
blocked overnight with 5% milk in Tris-buﬀered saline (TBS) and incu-
bated for 2 h at room temperature with primary antibody. After wash-
ing four times with TBS containing 0.05% Tween-20 (TBS-T), the
membranes were incubated with horseradish peroxidase-conjugated
secondary antibodies for 1 h and then washed four times with TBS-
T. The blots were developed using the ECL chemiluminescence reagent
kit according to the manufacturer’s instructions.
2.5. RNA extraction and Northern blot analysis
Total cellular RNA was extracted using the RNeasy Midi Kit (Qia-
gen). Thirty micrograms of total RNA from each cell line was electro-
phoresed in a 1.2% agarose/formaldehyde gel, transferred to a nylon
membrane by upward capillary transfer, and crosslinked by a UV
Stratalinker 2400 (Stratagene). The membrane was hybridized over-
night at 42 with a cDNA probe labeled with 32P by random priming
using Ready-To-GoTM DNA Labeling Beads (Amersham Biosci-
ences) in ULTRAhybTM Hybridization Buﬀer (Ambion) according
to the manufacturer’s speciﬁcations. The membrane was washed twice
in 2· SSC–0.1% SDS for 5 min and twice in 0.1· SSC–0.1% SDS for
15 min at 42 C and then autoradiographed.
2.6. Casein zymography
l-Calpain activity in cell extracts was analyzed by casein zymogra-
phy in a standard Tris-glycine system [26]. Brieﬂy, cultured cells were
washed and scraped into lysis buﬀer (50 mM HEPES, pH 7.6, 150 mM
sodium chloride, 10% glycerol, 1% Triton X-100, 5 mM EDTA,
10 mM b-mercaptoethanol, 100 mM phenylmethylsulfonyl ﬂuoride
and 10 lg/ml of leupeptin). After centrifugation at 12000 · g for
5 min at 4 C to remove any insoluble material, 30 lg of protein was
run on a non-denaturing acrylamide gel containing casein (0.2%, w/v)
at 125 V for 3 h. The gel was then removed and incubated overnight
at room temperature with 5 mM Ca2+ and 10 mM b-mercaptoethanol
in 25 mM Tris–HCl (pH 7.6) buﬀer, followed by ﬁxation and staining
with Coomassie brilliant blue R250. As a control, an identical gel was
treated with incubation buﬀer containing 5 mM EDTA in place of
Ca2+. Protease activity was detected as a clear band in the dark blue
background after destaining the gel.2.7. Wound-healing assay
The ability of cells to migrate in monolayer cultures was assessed by
a wound-healing assay. Prior to the assay, 6-well dishes were pre-
coated with 1.3 lg/ml of ﬁbronectin in PBS overnight at 4 C. Cells
were seeded and cultured to 90% conﬂuency. On the day of assay, a
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Fig. 1. Screening of cell lines and functional siRNAs and knockdown of human l-calpain. (A) Western blot analysis of l-calpain and m-calpain
expression in human cell lines. (B) Sequences of siRNAs used to knockdown human l-calpain. (C) The siRNAs synthesized in vitro by T7
polymerase (Ambion Inc.) were transiently transfected into HeLa cells. Forty-eight hours after transfection, the cells were lysed and whole cell lysates
were subjected to Western blot analysis as described under Section 2. (D) MCF-7 stable cell lines were generated as described under Section 2. Total
proteins extracted from wild-type, l-calpain siRNA-expressing or control siRNA-expressing MCF-7 stable cell lines were subjected to Western blot
analysis. (E) Northern blot analysis of total RNAs extracted from wild-type, l-calpain siRNA-expressing or control siRNA-expressing MCF-7 stable
cell lines. The DNA probes for l-calpain and GAPDH control were prepared as described under Section 2. (F) Casein zymogram. Thirty micrograms
of cell lysates from wild-type, l-calpain siRNA-expressing or control siRNA-expressing MCF-7 stable cell lines were run on a native acrylamide gel
containing casein, followed by incubation, ﬁxation and staining as described under Section 2.
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wounds were scratched with a sterile pipette tip through the cells mov-
ing perpendicular to the line drawn. The cells were then rinsed once
with PBS to remove any cellular debris and replaced with new medium
containing 10% of FBS. Photographs were taken just above and just
below each line marker immediately after wounding and at intervals
up to 36 h. The experiments were repeated in duplicate wells at least
three times.
2.8. Cell growth assay
Prior to seeding, 100-mm plates were pre-coated with 1.3 lg/ml of
ﬁbronectin in PBS overnight at 4 C. Cells were plated at a density
of 8 · 104 cells per plate. At indicated times, cells were trypsinized,
stained with trypan blue and counted by a hemocytometer. Three
counts were taken for each sample and two independent experiments
were preformed. The average was applied for calculating the cell
number.
2.9. Time lapse videomicroscopy
Cells were plated at 15% density onto a glass Delta T dish (0.15 mm;
Bioptechs, Inc., Butler, PA) coated with 1.3 lg/ml of ﬁbronectin and
allowed to culture overnight at 37 C under 5% CO2. The dish was par-
titioned into three compartments for testing three diﬀerent conditions.
On the day of the assay, the cell dish was placed directly onto a heated
stage after replacing the medium with CO2-independent L15 medium.Fig. 2. Knockdown of l-calpain reduces cell migration. (A) l-calpain siRNA
were seeded on six-well tissue culture dishes pre-coated with 1.3 lg/ml of ﬁ
wounded as described under Section 2 and photographed at the indicated i
results shown are mean ± S.E. from three independent experiments. Statis
P < 0.005 for 36 h). (C) The movement of l-calpain siRNA-expressing stab
measured by quantitative time lapse videomicroscopy as described under
independent experiments. Statistical analysis was performed by Student’s t tA Leica DMIRB inverted microscope with motorized Ludl hardware
was used to capture individual focused images for 10 h at 10-min inter-
vals on a CCD camera (Qimaging) attached to a PowerMac G5 com-
puter (Apple, Cuperttino, CA). Image capture and processing were
done using Openlab Software Version 3 (Improvision). Cell motility
was assessed by drawing a rectangular region of interest (ROI) encom-
passing each cell at time 0. The time-lapse movie for each stage posi-
tion was played and each cell was scored for motility according to
an arbitrary criterion: if most of a cell’s area exited the ROI at any
time, the cell was scored as motile.3. Results
3.1. Knockdown of l-calpain reduces cell migration
To study isoform-speciﬁc function of l-calpain, we screened
cell lines which speciﬁcally express l-calpain. We found that
MCF-7 cells express high level of l-calpain but not m-calpain
(Fig. 1A). We next used siRNAs to disrupt l-calpain expres-
sion. Speciﬁcally designed siRNAs (Fig. 1B) were screened
by thermodynamic proﬁling [24,25] and veriﬁed by transient
transfection into HeLa cells followed by Western blot analysis
(Fig. 1C). The results showed that two of these siRNAs, siR--expressing stable cell line and control siRNA-expressing stable cell line
bronectin and cultured to conﬂuent cell monolayers, which were then
ntervals. (B) The wound areas were measured and calculated and the
tical analysis was performed by Student’s t test (P = 0.086 for 18 h,
le MCF-7 cells and control siRNA-expressing stable MCF-7 cells was
Section 2. The results shown are mean ± S.E. of 60 cells from two
est (P < 0.001).
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l-calpain expression. siRNA2 displayed a lower internal
strand stability (approximately 6.2 kcal/mol) at the 5 0-anti-
sense (5 0-AS) terminus, while siRNA1 was enriched with nucle-
otides that had lower internal strand stability (approximately
7.6 kcal/mol) at position 9–14 (counting from the 5 0-AS
end) [24,25]. siRNA3 and siRNA4 did not meet these two cri-
teria and had no eﬀect on silencing l-calpain. siRNA2 was se-
lected for the subsequent study and named l-calpain siRNA,
whereas non-functional siRNA4 was used as negative control
siRNA.
Previous research indicated that l-calpain is a long-lived
protein with a metabolic half-life of approximately 5 days
[27]. In order to maximize the knockdown eﬃciency for func-
tional assays of l-calpain on cell migration, stable cell lines
expressing siRNAs were made with MCF-7 cells. Western blot
analysis revealed that l-calpain expression in the MCF-7 cells
stably transfected with the l-calpain siRNA-expressing plas-Fig. 3. Rescue of l-calpain expression results in restoration of a normal cell m
made at the siRNA targeting sequence of l-calpain-wild-type (l-calpain-wt) t
cell line was transiently transfected with pcDNA3.1 empty vector and pcDN
and 30 lg of total protein extract was then subjected to Western blot analysis
was transiently transfected with pcDNA3.1 empty vector and pcDNA3.1/l-ca
lysates from each cell line were subjected to a native acrylamide gel contain
under Section 2. (D) l-calpain siRNA-expressing MCF-7 stable cells were t
and pcDNA3.1/l-calpain-re, pcDNA3.1/m-calpain or empty vector. Sixteen
dishes and cultured to conﬂuent cell monolayers, which were then wounded
The same transfected cells were lysed and subjected to Western bolt analysis 7
7 cells were cotransfected with a GFP-expressing vector (pFERD/GFP) and
sample were subjected to the motile and static assay using time-lapse vid
performed by McNemar’s test (P < 0.05).mid was inhibited up to 70–80% as compared both to cells
transfected with the control siRNA-expressing plasmid, and
to wild-type MCF-7 cells (Fig. 1D). Northern blot analysis fur-
ther veriﬁed the disruption of l-calpain mRNA (Fig. 1E).
Casein zymography demonstrated that l-calpain activity was
signiﬁcantly reduced in the l-calpain siRNA-expressing stable
cell lines as compared to control siRNA-expressing stable cell
lines and wild-type MCF-7 cells (Fig. 1F). Thus, siRNA-med-
iated silencing of l-calpain leads to substantial inhibition of its
expression and activity in the MCF-7 stable cell line.
To determine whether selective silencing of l-calpain is suf-
ﬁcient to aﬀect normal cell migration, we carried out a wound-
healing assay and time-lapse videomicroscopy of the MCF-7
cells plated on 1.3 lg/ml of ﬁbronectin-coated surface that con-
fers an intermediate cell-substratum adhesiveness maximizing
cell migration [28,29]. When conﬂuent monolayers of transfec-
ted cells were analyzed for their ability to move to the
wounded area, control siRNA-expressing cells migrated intootility and morphology. (A) Six-site silent mutation of nucleotide was
o generate l-calpain-re. (B) l-calpain siRNA-expressing MCF-7 stable
A3.1/l-calpain-re respectively. Cells were lysed 72 h after transfection
. (C) Casein zymogram. The l-calpain siRNA-expressing stable cell line
lpain-re respectively. Seventy-two hours after transfection, 30 lg of cell
ing casein, followed by incubation, ﬁxation and staining as described
ransiently cotransfected with a GFP-expressing vector (pFERD/GFP)
hours after transfection, the cells were seeded on six-well tissue culture
as described under Section 2 and photographed at indicated intervals.
2 h after transfection. (E) The l-calpain siRNA-expressing stable MCF-
pCDNA3.1/l-calpain-re or empty vector. More than 105 cells in each
eomicroscopy as described under Section 2. Statistical analysis was
M. Wu et al. / FEBS Letters 580 (2006) 3246–3256 3251the open space within the ﬁrst 18 h and almost closed the
wound within 36 h (Fig. 2A). In contrast, most of the calpain
siRNA-expressing cells remained at the initial wound margin
after 18 h and the wound was only half-closed after 36 h.
The average recovery percentage of the wounded portion
was measured and calculated. Overall, knockdown of l-cal-
pain resulted in 45–50% of reduced recovery rate of the
wounded portion (Fig. 2B). Time-lapse videomicroscopy anal-
ysis showed that calpain siRNA-expressing cells moved at aFig. 3 (contmuch lower velocity (12.5 (m/h)) than that of the control siR-
NA-expressing cells (17.6 (m/h)) (Fig. 2C), which is consistent
with the wound-healing assay.
3.2. Rescue of l-calpain expression but not m-calpain expression
restores normal cell motility of MCF-7 cells
To determine if the phenotypes observed in the l-calpain
siRNA-expressing stable MCF-7 cell line is the direct conse-
quence of the knockdown of targeted l-calpain, we carriedinued)
Fig. 3 (continued)
3252 M. Wu et al. / FEBS Letters 580 (2006) 3246–3256out the rescue experiment by overexpressing wild-type l-cal-
pain and m-calpain. In order to avoid degradation of the trans-
fected l-calpain by the existing siRNA in the l-calpain
siRNA-expressing stable cell line, a six-site silent mutation
was made at the siRNA targeting sequence of wild-type l-cal-
pain (l-calpain-wt) to generate l-calpain-rescue (l-calpain-re)
plasmid (Fig. 3A). Since the changed codons were selected
based on the maximum frequency of codon usage, we antici-
pated a successful rescue of l-calpain expression. As expected,
a highly elevated expression level of l-calpain was achieved by
ectopic transfection of l-calpain-re plasmid into the l-calpain
siRNA-expressing stable cell line (Fig. 3B). The restoration of
l-calpain activity was also veriﬁed by casein zymography,
showing that the activity was fully recovered and even higher
than that in wild-type MCF-7 cells (Fig. 3C). Taken together,
rescue of l-calpain creates a normal level of activity and can be
further applied to analyze reverted phenotypes.
To test whether the revertant could reinstate l-calpain-re-
lated migration, the l-calpain siRNA-expressing MCF-7 sta-
ble cells were transfected with l-calpain-re-expressing vector,
m-calpain-expressing vector and empty vector respectively,
and then replated on ﬁbronectin at low density to facilitate cell
spreading and migration. An increase in the migration rate as
the direct consequence of l-calpain re-expression was demon-
strated by the wound-healing assay when l-calpain-re was
co-transfected with pFRED/GFP into conﬂuent l-calpain siR-
NA-expressing stable cells (Fig. 3D). However, expression of
m-calpain did not restore the l-calpain function for the cell
migration (Fig. 3D). The expression of the transfected l-cal-
pain and m-calpain was conﬁrmed by Western blot
(Fig. 3D). The motile/static assay by time lapse videomicros-
copy also demonstrated 75% increase of migration rate in
l-calpain-re-transfected cells compared to the control
(Fig. 3E). Therefore, MCF-7 cells lacking l-calpain show a
notable reduction in cell migration and translocation, whereas
the restored expression of l-calpain but not m-calpain estab-
lishes its activity.3.3. Knockdown of l-calpain alters cell morphology
In order to determine if the observed phenotype might be
caused by diﬀerent cell growth rates, we therefore counted cell
numbers at individual time points under the same culture con-
dition as that in the wound-healing assay. The result showed
that the growth rates of these two stable cells were similar(Fig. 4A). We next determined if the knockdown of l-calpain
aﬀects cell morphology that may be linked to the reduction of
cell mobility. MCF-7 cells expressing the control siRNA were
mostly cuboidal in shape and very few of them had some back-
ground with irregular shapes including short protrusions
(Fig. 4B). However, compared to the control, 6-fold more of
the l-calpain siRNA-expressing MCF-7 stable cells displayed
ﬁlopodial projections and a highly elongated tail (Fig. 4B
and C) that seemed to prevent cell spreading and migration
through a reduced rear detachment ability. More interestingly,
recovery of expression of l-calpain by transfecting the l-cal-
pain siRNA-expressing MCF-7 stable cell line with the l-cal-
pain-re-expressing vector restored the cell morphology to
that of wild-type MCF-7 cells, whereas the phenotype in the
control vector transfection essentially maintained that of the
l-calpain siRNA-expressing stable cell line (Fig. 4B and C).
Together, these results reveal that decreased l-calpain activity
is related to altered morphology of MCF-7 cells.3.4. Knockdown of l-calpain increases the stability of
intracellular ﬁlamin and talin
It has been demonstrated that integrin-mediated signals tar-
get calpain to focal adhesion complexes, in which some com-
ponents have been identiﬁed as possible calpain substrates.
However, the relevant substrates in vivo for calpain-dependent
adhesion turnover, cell rear detachment and subsequent cell
movement remain unclear. In an attempt to clarify potential
substrates involved in l-calpain-regulated migration, the
expression level and proteolysis of several focal adhesion com-
ponents including ﬁlamin A, talin and vinculin were studied.
As shown in Fig. 5A, native ﬁlamin A (280 kDa) was cleaved
giving rise to a 190-kDa fragment (N-terminus) and a 90-kDa
fragment (C-terminus) in the control siRNA-expressing stable
cell line. Knockdown of l-calpain by siRNA dramatically re-
duced the production of both the 190-kDa fragment and 90-
kDa fragment (Fig. 5A). Similarly, intact talin (230 kDa) also
appeared to be proteolyzed producing a 190-kDa fragment
that was observed in the control siRNA-expressing stable cell
line and absent in the l-calpain siRNA-expressing stable cell
line (Fig. 5A). Both 190-kDa and 90-kDa cleavage fragments
of ﬁlamin A and the 190-kDa proteolytic product of talin
are identical in size to the previously identiﬁed calpain-medi-
ated cleavage products of ﬁlamin [30] and talin [31,32] in vitro.
In accordance with the full recovery of l-calpain activity,
even improved cleavage of ﬁlamin and talin were seen in cells
rescued by over expression of l-calpain, but not m-calpain
(Fig. 5B). This pattern suggested that l-calpain is speciﬁcally
responsible for cleavage of ﬁlamin and talin in MCF-7 cells.
In either cell type, the level of vinculin was unchanged
(Fig. 5). Thus, these results suggest that knockdown of l-cal-
pain increases the intracellular stability of ﬁlamin and talin.
Cleavage of these two adhesion components in vivo by l-cal-
pain may deﬁne the central mechanism by which l-calpain reg-
ulates cell motility.4. Discussion
The biological function of calpains has been extensively
studied using pharmacological inhibitors (for review, see Refs.
[3–13]). However, these functional studies are based on com-
Fig. 4. Knockdown of l-calpain does not aﬀect growth but causes morphological change of MCF-7 cells. (A) l-calpain siRNA-expressing stable cell
line and control siRNA-expressing stable cell line were seeded on 100-mm dishes pre-coated with 1.3 lg/ml of ﬁbronectin at a density of 8 · 104 cells/
dish. Viable cells were then counted at the times indicated. (B) l-calpain siRNA-expressing and control siRNA-expressing stable cell lines were plated
on 1.3 lg/ml ﬁbronectin at 10% density and incubated at 37 C under 5% CO2. Phase-contrast images were acquired 16 h later using a 32· objective.
The arrows highlight extended ﬁlopodia and/or elongated tails. (C) The number of the cells showing extended ﬁlopodia and/or an elongated tail was
counted and the percentage of the total number of cells was calculated. The results shown are mean ± S.E. from at least three independent
experiments. Statistical analysis was performed by Student’s t test.
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3254 M. Wu et al. / FEBS Letters 580 (2006) 3246–3256bined eﬀects of l-calpain and m-calpain since the calpain
inhibitors used inactivate both enzymes [14–16]. RNAi has a
great potential to distinguish distinct functions of each mem-
ber in a closely related gene family. Recently, Franco et al.
have knocked-down the expression of l-calpain and m-calpain
in mouse embryonic ﬁbroblasts, and found that knock-down
lines of m-calpain altered cell membrane protrusion kinetics
and adhesion dynamics, but knock-down lines of l-calpain
showed normal morphology [23]. Similarly, Honda et al have
found that knockdown of m-calpain, but not l-calpain, in-
duced mitotic delay with chromosome misalignment [33]. In
this study, using a similar gene knockdown method, we dem-
onstrate the function of l-calpain in cell migration. To avoid
the eﬀect of m-calpain on the observation, we selected a cell
line, human breast cancer MCF-7 cells, which do not express
m-calpain. We found that knockdown of l-calpain expression
led to a reduction in cell migration. The isoform-speciﬁc func-
tion of l-calpain was further conﬁrmed by a rescue experiment
as overexpression of l-calpain but not that of m-calpain could
restore the cell migration rate. Recently Satish et al. reported
that both l-calpain and m-calpain are involved in the regula-
tion of cell migration of keratinocytes, but through a diﬀerent
signaling pathway. M-calpain is activated by EGF receptor
signaling whereas l-calpain is activated by interferon-inducible
protein 9 [34]. Taken together, these ﬁndings suggest that l-
calpain and m-calpain have diﬀerent biological functions.
Cell migration can be considered as a cycle of multiple steps,
including the forward extension of a protrusion, the stable
attachment at the leading edge of the protrusion, the contrac-
tion and forward movement of cell body, and the release of
adhesion and retraction at the cell rear. We found that l-cal-
pain siRNA-expressing MCF-7 stable cells displayed increased
ﬁlopodial projections and a highly protrusive morphology.
This morphological change can cause either an increase or de-
crease in cell spreading and migration depending on which
migration step is aﬀected. Although the function of calpain
as a positive regulator in cell migration has been well demon-
strated, the mechanism of cell movement regulated by calpains
remains unclear. Huttenlocher et al. reported that inhibition of
calpain activity resulted in a change in CHO cell morphologywith many cells showing a highly elongated tail, suggesting
that calpain disrupts focal adhesions at the rear of migrating
cells [35]. However, Potter et al. found that ﬁlopodial and
lamellipodial projection formation were severely impaired in
NIH 3T3 cells treated with calpain inhibitors, suggesting that
calpain activity is required for forward protrusion and spread-
ing during cell migration [36]. It was also reported that bovine
aortic-endothelial cell spreading was remarkably disrupted by
calpain inhibitors [37]. Taken together, calpains may have mul-
tiple actions that control cell migration at diﬀerent steps. The
present study suggests that l-calpain may regulate the migra-
tion of MCF-7 cells by disassembling focal complexes at the
rear of the cell and releasing tail attachment.
Calpains have many substrates in vivo, including a number
of focal adhesion complex proteins and cytoskeletal proteins
[3]. In contrast to the results observed in mouse embryonic
ﬁbroblasts where talin was cleaved by m-calpain but not l-cal-
pain [22,23], we found that talin and ﬁlamin cleavage de-
creased in l-calpain knocked-down MCF-7 cells, and
increased again in cells rescued by overexpression of l-calpain,
but not m-calpain, suggesting that calpains have distinct sub-
strate speciﬁcities in diﬀerent cells. To our knowledge, this is
the ﬁrst report demonstrating the proteolysis of ﬁlamin during
calpain-regulated cell locomotion, although reports indicated
previously that cleavage of ﬁlamin by calpain in vivo is associ-
ated with blood coagulation and platelet physiology [38–40].
Based on previous in vitro ﬁndings it is suspected that cal-
pains are activated by intracellular Ca2+ ﬂuxes of 5–50 lM
for l-calpain and 0.2–1 mM for m-calpain [3]. Moreover, spa-
tial patterns of l-calpain and m-calpain are probably diﬀerent
in multiple subcellular locations [18,41]. It is possible that the
activation process and favorable substrates of l-calpain and
m-calpain in vivo are diﬀerent although they cleave most sub-
strates in a similar manner. As a result, both l-calpain and m-
calpain play important roles in cell migration, but each of them
may function in diﬀerent cell types and/or under diﬀerent cir-
cumstances, as revealed in the present and previous studies
[23,33,34].
Since calpain-regulated cell adhesion and migration have
been historically linked to pathophysiological issues in tumor
metastasis, wound healing and the immune and inﬂammatory
responses, functional dissection of individual isoforms and
speciﬁc therapeutic treatments are even more crucial. In addi-
tion, many human disorders are caused by overactivation of
single isoforms of calpains. For example, lens m-calpain is
thought to be over-activated in cataracts leading to crystalline
precipitation and, ultimately, lens opacity [15,42]. m-calpain
can be targeted for limiting prostate cancer invasion [43].
An excessive amount of m-calpain is also found in arthritic
knee joints of mice [44]. l-calpain overexpression is associated
with increased malignancy in human renal cell carcinoma
[45]. However, the current lack of potent, selective and cell-
permeable calpain inhibitors makes it diﬃcult to control these
situations. RNAi, which has been proven to be a powerful
tool for dissecting the functions of each calpain isoform,
may provide us with an attractive therapeutical approach in
the treatment of various pathological disorders associated with
over-activation of l-calpain and/or m-calpain, or other speciﬁc
calpain family members. However, the isoform-speciﬁc
function of l-calpain in cell adhesion was not experimentally
demonstrated.
Fig. 5. Knockdown of l-calpain increases the stability of intracellular ﬁlamin and talin. (A) l-calpain siRNA-expressing MCF-7 stable cell line and
control siRNA-expressing stable cell line were seeded on dishes coated with 1.3 lg/ml of ﬁbronectin. After 24 h incubation, cells were processed for
Western blot analysis with the antibodies as indicated. (B) l-calpain siRNA-expressing cell line was transiently transfected with pCDNA3.1 empty
vector, pcDNA3.1/l-calpain-re and pcDNA3.1/m-calpain respectively. Twenty-four hours after transfection, cells were detached and replated on
dishes coated with 1.3 lg/ml of ﬁbronectin. After additional 24 h incubation, cells were processed for Western blot analysis with the antibodies as
indicated. Molecular mass (kDa) is shown to the left of the gels.
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